Intratympanic Steroid Perfusion for the Treatment of Ménière's Disease: A Retrospective Study

We conducted a retrospective outcomes review of the charts of 22 patients with Ménière's disease who were treated with intratympanic perfusion of methylprednisolone and/or dexamethasone. Outcomes were determined by subjective assessment of vertigo control and by objective changes in audiometric pure-tone average (PTA) and speech discrimination score (SDS). These evaluations were made at the first postperfusion visit (short term) and at least 12 months later (long term). In the short term, 12 patients (54.5%) achieved vertigo control, 4 patients (18.2%) demonstrated a greater than 10-dB improvement in PTA, and 1 patient (4.5%) experienced an increase in SDS of at least 15%. In the long term, the corresponding numbers of patients were 4 (18.2%), 2 (9.1%), and 1 (4.5%). The level of hearing ultimately deteriorated in 9 patients (40.9%). These findings suggest that intratympanic steroid perfusion does not result in any long-term alleviation of vertigo or hearing loss. However, the short-term alleviation of vertigo seen in approximately half of these patients suggests that this treatment may be useful for the temporary relief of symptoms of Ménière's disease.

[1]  H. Silverstein,et al.  Intratympanic Steroid Treatment of Inner Ear Disease and Tinnitus (Preliminary Report) , 1996, Ear, nose, & throat journal.

[2]  L. Parnes,et al.  Corticosteroid Pharmacokinetics in the Inner Ear Fluids: An Animal Study Followed by Clinical Application , 1999, The Laryngoscope.

[3]  S. Chandrasekhar,et al.  Dexamethasone pharmacokinetics in the inner ear: comparison of route of administration and use of facilitating agents. , 2000, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[4]  K. Rarey,et al.  Receptors for Glucocorticoids in the Human Inner Ear , 1996, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[5]  D. G. Drescher,et al.  Glucocorticoid receptors in the mammalian inner ear: RU 28362 binding sites , 1994, Hearing Research.

[6]  M. Arriaga,et al.  Hearing results of intratympanic steroid treatment of endolymphatic hydrops , 1998, The Laryngoscope.

[7]  L. Chirkova,et al.  [Treatment of vestibular disorders with neurotropic drugs]. , 1975, Zhurnal ushnykh, nosovykh i gorlovykh boleznei = The journal of otology, rhinology, and laryngologie [sic].

[8]  M. Seidman,et al.  Effect of transtympanic injection of steroids on cochlear blood flow, auditory sensitivity, and histology in the guinea pig. , 1998, The American journal of otology.

[9]  J. Mcelveen,et al.  Intratympanic Steroid Injections for Intractable Ménière's Disease , 2001, The Laryngoscope.

[10]  H. Silverstein,et al.  Inner ear perfusion and the role of round window patency. , 1997, The American journal of otology.

[11]  H. Silverstein,et al.  Dexamethasone inner ear perfusion for the treatment of Meniere's disease: a prospective, randomized, double-blind, crossover trial. , 1998, The American journal of otology.

[12]  G. Gates,et al.  Committee on Hearing and Equilibrium Guidelines for the Diagnosis and Evaluation of Therapy in Meniere's Disease ∗ , 1995 .

[13]  E. Sakata,et al.  Treatment of vestibular disorders. , 1991, Acta oto-laryngologica. Supplementum.

[14]  K. Rarey,et al.  Localization of glucocorticoid receptors and glucocorticoid receptor mRNAs in the rat cochlea , 1993, The Laryngoscope.

[15]  E. Smouha,et al.  Natural History vs. Surgery for Meniere's Disease , 1989, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.